Dr. Michal Freud-Silverberg, Ph.D – Clinical Affairs (CA)
Dr. Freud-Silverberg has a Ph.D in Biochemistry and has been working in clinical trials since 1997. Her professional experience ranges from monitoring to project management of international studies. She has been directly involved in Phase I - Phase III studies (sponsored by pharmaceutical companies) in several therapeutic areas (cardiology - acute and chronic, HTN, systemic lupus erythe- matosus, vaccines and schizophrenia). Dr. Freud-Silverberg’s current responsibilities include: leadership of the studies and study team coordination, writing SOPs and study documents, and training (GCP, SOPs, regulatory requirements and study speciﬁc training).